Co-incubation of Oocytes With Sperm: Defining the Optimal Incubation Time

NCT ID: NCT04627545

Last Updated: 2024-08-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

55 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-11-03

Study Completion Date

2023-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The current pilot study aims to evaluate the fertilization rates between sibling oocytes subjected to short incubation (2h) versus overnight incubation (16-20h). As secondary objectives, the abnormal fertilization, embryo development, blastocyst biopsy and euploid rates will be analyzed.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

All patients for whom at least 6 cumulus oocytes complexes (COCs) are assigned to IVF, with normal sperm parameters, are eligible for the study. An electronically generated randomization list will allocate the first half of the oocytes to one arm and the other half of the oocytes to the second arm. In case an odd number of oocytes will be inseminated, one extra oocyte will be allocated to the first arm. In this prospective observational pilot study, the fertilization potential of 40 patients will be evaluated.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infertility

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Oocytes of one patient will be evenly and randomly distributed between two timings of exposure to sperm: 2h exposure versus overnight exposure (16-20h)
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

IVF: 2h exposure

Half of a patients' oocytes will be subjected to 2h exposure to sperm

Group Type EXPERIMENTAL

2h exposure to sperm for IVF

Intervention Type OTHER

Oocytes will only be briefly (2h) exposed to progressive motile sperm for insemination

IVF: overnight exposure

Half of a patients' oocytes will be subjected to overnight incubation with sperm (=usual practice).

Group Type ACTIVE_COMPARATOR

overnight exposure to sperm for IVF

Intervention Type OTHER

Oocytes will be exposed for a longer duration (overnight, 16-20h) to progressive motile sperm for insemination

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

2h exposure to sperm for IVF

Oocytes will only be briefly (2h) exposed to progressive motile sperm for insemination

Intervention Type OTHER

overnight exposure to sperm for IVF

Oocytes will be exposed for a longer duration (overnight, 16-20h) to progressive motile sperm for insemination

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

short exposure long exposure

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Sperm parameters

* Sperm concentration before capacitation: \>15 million per ml (WHO) Total motility (PR+NP %): \>40 (WHO) Progressive motility (PR %):\>32 (WHO)
* Sperm concentration after capacitation: \>0.6 million per ml (not WHO defined) Progressive motility (PR %):\>65 (WHO)
* ≥6 COCs assigned to IVF
* BMI ≤35 kg/m2
* Female age 18 to ≤ 43 years
* All ovarian stimulation protocols
* Fresh ejaculates
* Abstinence duration 2-5 days
* Presence or absence of sperm morphology data: as we do not have a diagnostic sperm analysis for all patients, the presence or absence of \>4% normal morphology (WHO) will not be taken into account, even with known low (\<4%) normal morphology
* Couples requesting Preimplantation Genetic Testing for Aneuploidies
* Arab population

Exclusion Criteria

* If the volume to be added after IVF is insufficient to perform IVF on all needed oocytes
* Presence of \>1 million per ml round cells in the ejaculate
* If a couple's previous cycle was included in the study
* Previous history of fertilization failure or \<50% fertilisation
* Globozoospermia
* PCO according to the Rotterdam criteria
* Progesterone \>1.5 ng/ml on the day of trigger
Minimum Eligible Age

18 Years

Maximum Eligible Age

43 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

ART Fertility Clinics LLC

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Neelke De Munck, PhD

Role: PRINCIPAL_INVESTIGATOR

ART Fertility Clinics

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

ART Fertility Clinics

Abu Dhabi, , United Arab Emirates

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Arab Emirates

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2010-ABU-010-ND

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

In Vitro Follicle Activation
NCT02496598 TERMINATED NA
Selection of Embryos by Time-lapse
NCT01138631 COMPLETED NA
Automated Sperm Selection
NCT05240469 RECRUITING NA